APIM050141: DEFACTINIB (VS-6063, PF-04554878)
CAS No.: 1073154-85-4.
Purity: >99% (HPLC at 214 and 254 nm).
QC: HPLC-MS, 1HNMR, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050209: NVP-BHG712 (BHG-712)
CAS No.: 940310-85-0.
Purity: 99.5% by HPLC at 214 and 254 nm.
QC: HPLC, H-NMR and Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.APIM050253: VATALANIB
CAS No.: 212141-54-3.
Purity: >99% (HPLC).
QC: 1HNMR, HPLC.
Solubility: Soluble in water.APIM050307: PACLITAXEL
CAS No.: 33069-62-4.
Purity: >99.5% (by HPLC).
QC: HPLC, H-NMR, and Quantitative Elemental Analysis Report.
Solubility: Soluble in alcohols, and common organic solvents.C041P: Briakinumab Biosimilar, IL-12 / IL-23 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade briakinumab biosimilar specifically binds to the human interleukin-12 (IL-12) and interleukin-23 (IL-23).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by briakinumab.